Assessing Dupilumab Acceptability Requires Accounting for Treatment Discontinuation.
Kaplan F
Australasian Journal of DermatologyIn the feed 21 Sep 2026, published online 20 Sep 2026, issue 2026 Sep 20, added to PubMed 21 Sep 2026
Topics: Atopic dermatitis & eczema
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42764598 · DOI 10.1111/ajd.70217